Skip to content

Health— page 24

health

GSK to advance mRNA flu vaccine to late-stage trial

(Corrects paragraph 4 to clarify that GSK plans to start more than 20, not 25, late-stage trials in 2026) Sept 1 (Reuters) – GSK said on Tuesday it will advance its mRNA-based seasonal influenza vaccine candidate to a late-stage trial after mid-stage data showed it generated stronger immune response

· SRN Health
GSK to advance mRNA flu vaccine to late-stage trial
health

Novartis pauses trials of experimental cell therapy after three deaths

Sept 1 (Reuters) – Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late August, after three patients died. The halt was implemented on August 24 after Novartis was notified of three cases of

· SRN Health
Novartis pauses trials of experimental cell therapy after three deaths
health

GLP-1 weight loss drugs effective even at low starter doses

By Nancy Lapid Aug 31 (Reuters) – People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea than those who graduate to higher manufacturer-recommended doses, a new study suggests. And they

· SRN Health
GLP-1 weight loss drugs effective even at low starter doses
health

Teladoc appoints insurance executive Michael Grasher as CFO

Aug 31 (Reuters) – Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing in an industry veteran to help the virtual healthcare company navigate rising demand for its insurance-covered business. Here are some more details: • The appointment comes about a

· SRN Health
health

More than 6,000 people infected with Ebola in Congo, government figures show

DAKAR, Aug 31 (Reuters) – The number of confirmed Ebola cases in the Democratic Republic of Congo has passed the 6,000 mark, government data showed on Monday. The epidemic has become the largest in the central African country’s history, surpassing the previous worst outbreak that lasted from 2018 to

· SRN Health
More than 6,000 people infected with Ebola in Congo, government figures show
health

Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push

By Padmanabhan Ananthan Aug 31 (Reuters) – Eli Lilly said on Monday it would acquire privately held Merida Biosciences for up to $2.88 billion in cash, strengthening its immunology portfolio with an experimental treatment for thyroid-related autoimmune conditions. Lilly has been on an acquisition sp

· SRN Health
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
health

Samsung Biologics to launch takeover bid for PolyPeptide in September

Aug 31 (Reuters) – Samsung Biologics will launch its takeover offer for Swiss contract drugmaker PolyPeptide Group in September, the South Korean company said in an offer prospectus on Monday. The companies had announced in July that Samsung Biologics would launch an offer of 1.46 billion Swiss fran

· SRN Health
Samsung Biologics to launch takeover bid for PolyPeptide in September
health

China’s Fosun International wins approval for ClubMed Hong Kong spin-off

Aug 31 (Reuters) – Fosun International has received approval from the Hong Kong Stock Exchange to proceed with the proposed spin-off and separate listing of its resort-operator unit ClubMed Lifestyle, it said late on Friday. Details of the initial public offering (IPO) are yet to be finalised, the C

· SRN Health
health

US FDA approves Takeda, Protagonist’s drug for rare blood cancer

By Kamal Choudhury and Mariam Sunny Aug 28 (Reuters) – The U.S. Food and Drug Administration has approved a first-of-its-kind drug from Takeda Pharmaceutical and Protagonist Therapeutics to treat a rare blood cancer, the health regulator said on Friday. The approval of rusfertide brings a highly ant

· SRN Health
US FDA approves Takeda, Protagonist’s drug for rare blood cancer
health

Juul gets OK to sell updated vaping device with age-gating technology

WASHINGTON (AP) — Vaping company Juul Labs on Friday received federal permission to sell an updated version of its e-cigarette, which includes an optional age-verification system designed to prevent underage use. The decision from the Food and Drug Administration allows the company to sell a new ver

· SRN Health
Juul gets OK to sell updated vaping device with age-gating technology
health

FDA allows marketing of Juul’s new e-cigarettes and flavored pods

Aug 28 (Reuters) – The U.S. Food and Drug Administration on Friday authorized the marketing of three new ‘JUUL2’ e-cigarette products, the latest in a series of approvals for nicotine products the agency says may offer a lower-risk alternative to traditional cigarettes. Here are some details: • The

· SRN Health
FDA allows marketing of Juul’s new e-cigarettes and flavored pods
health

Death toll rises in Nepal-China border disaster as a lake poses new flood threat

KATHMANDU, Nepal (AP) — Rescuers pulled out survivors caked in dark brown mud and helicopters lifted stranded people to safety Friday, as Nepal and China raced to respond to catastrophic flash floods that killed more than 500 people and left more than 1,500 missing. Rescue teams were put on high ale

· SRN Health
Death toll rises in Nepal-China border disaster as a lake poses new flood threat
health

Explainer-What to know about postpartum mental illness

By Nancy Lapid Aug 28 (Reuters) – After a month-long trial, a Massachusetts jury is deciding the fate of Lindsay Clancy, a mother who killed her three young children in 2023 and then tried to kill herself. Her defense lawyer says her actions were due to her ‌suffering from the most severe form of po

· SRN Health
Explainer-What to know about postpartum mental illness
health

Factbox-What other health conditions could GLP-1 weight-loss drugs treat?

Aug 28(Reuters) – The U.S. FDA on Friday approved the use of Eli Lilly’s Mounjaro to reduce the chances of heart attack or stroke in high-risk patients with type 2 diabetes, marking the latest in a race by makers of GLP-1 medicines to expand their use. Lilly’s Danish rival Novo Nordisk had secured t

· SRN Health
health

Aid group MSF opens new Ebola treatment centre in eastern Congo

GENEVA, Aug 28 (Reuters) – French aid group Medecins Sans Frontieres said on Friday it had opened a new Ebola treatment centre in eastern Democratic Republic of Congo. Bed shortages are seen as one of many challenges in controlling the outbreak, which is the second deadliest ever and outpacing conta

· SRN Health
Aid group MSF opens new Ebola treatment centre in eastern Congo
health

BioNTech halts mRNA colorectal cancer vaccine trial after safety review

By Bhanvi Satija and Sriparna Roy Aug 28 (Reuters) – BioNTech SE said it will end a mid-stage study of its experimental mRNA cancer vaccine after an independent committee found the treatment was unlikely to help colorectal cancer patients live longer, sending the company’s U.S.-listed shares 7.5% lo

· SRN Health
BioNTech halts mRNA colorectal cancer vaccine trial after safety review
health

US FDA approves Lilly’s Mounjaro to reduce cardiovascular risk

Aug 28 (Reuters) – Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to reduce the chances of heart attack or stroke in adults with type 2 diabetes who are at high risk of cardiovascular events. Mounjaro is the company’s diabetes drug that targets the GLP-1 protein and is

· SRN Health
US FDA approves Lilly’s Mounjaro to reduce cardiovascular risk